Concepedia

Mitchell Mathis

MM

Statistics

Publications

6

Citations

189

H-Index

6

Active since

2012

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Mitchell Mathis is an author at Center for Drug Evaluation and Research specializing in medicine, pharmacotherapy, and drug discovery.

Top concepts

Publications per year

2012–2020

6

Publications

6

CYP2D6 Genotype Information to Guide Pimozide Treatment in Adult and Pediatric Patients

Hobart Rogers, Atul Bhattaram, Issam Zineh et al. · The Journal of Clinical Psychiatry · 2012 · 48 citations

The US Food and Drug Administration’s Perspective on the New Antidepressant Vortioxetine

Jing Zhang, Mitchell Mathis, Jenn W. Sellers et al. · The Journal of Clinical Psychiatry · 2014 · 37 citations

Projection of physical conditions in the North Sea for the 21st century

Mitchell Mathis, Thomas Pohlmann · Climate Research · 2014 · 35 citations · Full text

Efficient Trial Design — FDA Approval of Valbenazine for Tardive Dyskinesia

Michael C. Davis, Brian J. Miller, Jasmeet K. Kalsi et al. · New England Journal of Medicine · 2017 · 26 citations

, , +14

Regulatory and Scientific Issues in Studies to Evaluate Sexual Dysfunction in Antidepressant Drug Trials

Ni A. Khin, Phillip D. Kronstein, Peiling Yang et al. · The Journal of Clinical Psychiatry · 2015 · 22 citations

1–5 of 6